| Literature DB >> 35512457 |
Gianluca Paternoster1, Gianfranco Belmonte2, Enrico Scarano2, Pietro Rotondo2, Diego Palumbo3, Alessandro Belletti4, Francesco Corradi5, Pietro Bertini6, Giovanni Landoni7, Fabio Guarracino6.
Abstract
PURPOSE: To validate the role of Macklin effect on chest CT imaging in predicting subsequent occurrence of pneumomediastinum/pneumothorax (PMD/PNX) in COVID-19 patients.Entities:
Keywords: Acute respiratory distress syndrome; Barotrauma; Computed tomography; Intensive care; Mechanical ventilation; Pneumomediastinum; Pneumothorax
Mesh:
Year: 2022 PMID: 35512457 PMCID: PMC9020841 DOI: 10.1016/j.rmed.2022.106853
Source DB: PubMed Journal: Respir Med ISSN: 0954-6111 Impact factor: 4.582
Fig. 1Macklin effect in a COVID-19 patient. Lung parenchyma windowed CT images demonstrate [a] a crescent collection of air contiguous to the middle lobar bronchovascular sheath as well as interstitial emphysema in the left upper lobe, both representing Macklin effect (red arrows). Seven days later [b], pneumomediastinum occurred. . (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
Fig. 2Lung parenchyma window axial (a) and coronal (b) CT scans of patient suffering from SARS-CoV-2 infection, subjected to invasive mechanics ventilation, show: central Macklin effect (black arrow) in association with pneumomediastinum (white arrow), pneumothorax (white arrow heads), subcutaneous emphysema (black star) and pneumoperitoneum (black arrow head).
Baseline characteristics and clinical course of the 33 patients with Macklin effect on baseline chest CT scan.
| Patients Characteristics | |
Male sex, n (%) | 23 (69.9) |
Age, years | 65.8 ± 8.6 |
BMI, kg/m2 | 29.4 ± 5.3 |
| Comorbidities | |
Hypertension, n (%) | 11 (39.3) |
Cardiovascular disease (excluding hypertension), n (%) | 9 (27.2) |
Diabetes, n (%) | 10 (30.3) |
COPD, n (%) | 10 (30.3) |
CKD, n (%) | 2 (6.1) |
Malignancy, n (%) | 5 (15.1) |
| O2 supplementation at the time of the first CT scan | |
No supplemental oxygen, n (%) | 0 (0) |
Supplemental oxygen (FiO2 0.50 to 0.80), n (%) | 33 (100) |
Non-invasive ventilation/CPAP, n (%) | 0 (0) |
Invasive ventilation | 0 (0) |
| Barotrauma characteristics | |
At least one barotrauma event, n (%) | 32 (96.9) |
Pneumomediastinum alone, n (%) | 14 (42.4) |
Pneumothorax alone, n (%) | 8 (24.2) |
Pneumomediastinum and pneumothorax, n (%) | 10 (30.3) |
Subcutaneous emphysema, n (%) | 11 (33.3) |
BMI: body mass index; CKD: chronic kidney disease; COPD: chronic obstructive pulmonary disease; CPAP: continuous positive airway pressure; ICU: intensive care unit; SpO2: peripheral oxygen saturation; °C: Celsius degrees.
Fig. 3Inclusion/exclusion flowchart.
Respiratory parameters for the first 7 days after Intensive Care Unit admission.
| Day 1 | Day 2 | Day 3 | Day 4 | Day 5 | Day 6 | Day 7 | |
|---|---|---|---|---|---|---|---|
| PaO2/FiO2 ratio | 89.8 ± 38.5 | 85.3 ± 19.3 | 91.1 ± 19.7 | 91.2 ± 21.9 | 90.3 ± 22.7 | 86.1 ± 16.4 | 82.2 ± 19.7 |
| PaCO2 (mmHg) | 47.7 ± 8.9 | 47.5 ± 9.3 | 47.3 ± 9.7 | 46.8 ± 9.2 | 45.3 ± 10.0 | 45.0 ± 11.4 | 46.9 ± 0.1 |
| PEEP (cmH2O) | 9.2 ± 1.8 | 9.1 ± 2.3 | 9.5 ± 2.3 | 10.2 ± 3.0 | 9.6 ± 1.5 | 9.3 ± 1.7 | 9.7 ± 2.4 |
Continuous variables are presented as mean ± standard deviation.
PaO2/FiO2 ratio: ratio between arterial partial oxygen pressure (PaO2) and oxygen inspired fraction (FiO2); PaCO2: Carbon dioxide partial arterial pressure; PEEP: Positive End Expiratory Pressure.